Serum bone biomarkers and oral/systemic bone loss in humans

Journal of Dental Research

Volumn 90, Issue 6, 2011, Pages 747-751

  Payne, J B ^a   Stoner, J A ^b   Lee, H M ^c   Nummikoski, P V ^d   Reinhardt, R A ^a   Golub, L M ^c  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^c STONY BROOK UNIVERSITY   (United States)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

bone; osteopenia; periodontitis; post menopausal; serum biomarkers; subantimicrobial dose doxycycline

Indexed keywords

ALKALINE PHOSPHATASE; ALPL PROTEIN, HUMAN; ANTIINFECTIVE AGENT; BIOLOGICAL MARKER; BONE DENSITY CONSERVATION AGENT; COLLAGEN TYPE 1; COLLAGEN TYPE I TRIMERIC CROSS LINKED PEPTIDE; COLLAGEN TYPE I TRIMERIC CROSS-LINKED PEPTIDE; DOXYCYCLINE; OSTEOCALCIN; PEPTIDE;

AGED; ALVEOLAR BONE LOSS; ARTICLE; BLOOD; BONE DENSITY; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; METABOLIC BONE DISEASE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; STATISTICAL MODEL;

AGED; ALKALINE PHOSPHATASE; ALVEOLAR BONE LOSS; ANTI-BACTERIAL AGENTS; BIOLOGICAL MARKERS; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; BONE DISEASES, METABOLIC; CHILD; COLLAGEN TYPE I; DOUBLE-BLIND METHOD; DOXYCYCLINE; FEMALE; HUMANS; LINEAR MODELS; MIDDLE AGED; OSTEOCALCIN; PEPTIDES;

EID: 79956055025     PISSN: 00220345     EISSN: 15440591     Source Type: Journal    
DOI: 10.1177/0022034511402993     Document Type: Article

References (20)

1. Albandar JM, Brunelle JA, Kingman A. Destructive periodontal disease in adults 30 years of age and older in the United States, 1988-1994. J Periodontol. 1999 ; 70: 13-29
2. Bashutski JD, Eber RM, Kinney JS, Benavides E, Maitra S, Braun TM, et al. Teriparatide and osseous regeneration in the oral cavity. N Engl J Med. 2010 ; 363: 2396-2405
3. Blumsohn A, Marin F, Nickelsen T, Brixen K, Sigurdsson G, Gonzalez de la Vera J, et al. Early changes in biochemical markers of bone turnover and their relationship with bone mineral density changes after 24 months of treatment with teriparatide. Osteoporos Int. 2011 ;:
4. Giannobile WV, Lynch SE, Denmark RG, Paquette DW, Fiorellini JP, Williams RC. Crevicular fluid osteocalcin and pyridinoline cross-linked carboxyterminal telopeptide of type I collagen (ICTP) as markers of rapid bone turnover in periodontitis. A pilot study in beagle dogs. J Clin Periodontol. 1995 ; 22: 903-910
5. Golub LM, Ramamurthy NS, Llavaneras A, Ryan ME, Lee HM, Liu Y, et al. A chemically modified nonantimicrobial tetracycline (CMT-8) inhibits gingival matrix metalloproteinases, periodontal breakdown, and extra-oral bone loss in ovariectomized rats. Ann NY Acad Sci. 1999 ; 878: 290-310 (Pubitemid 29353577)
6. Golub LM, Lee HM, Stoner JA, Reinhardt RA, Sorsa T, Goren AD, et al. Doxycycline effects on serum bone biomarkers in post-menopausal women. J Dent Res. 2010 ; 89: 644-649
7. Hausmann E, Allen K, Carpio L, Christersson LA, Clerehugh V. Computerized methodology for detection of alveolar crestal bone loss from serial intraoral radiographs. J Periodontol. 1992 ; 63: 657-662
8. Jeffcoat MK, Reddy MS, Webber RL, Williams RC, Ruttimann U. Extra oral control of geometry for digital subtraction radiography. J Periodontal Res. 1987 ; 22: 396-402
9. Kushida K, Takahashi M, Kawana K, Inoue T. Comparison of markers for bone formation and resorption in premenopausal and postmenopausal subjects, and osteoporosis patients. J Clin Endocrinol Metab. 1995 ; 80: 2447-2450
10. Manolagas SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev. 2000 ; 21: 115-137 (Pubitemid 32275592)
11. Marx RE, Cillo JE, Ulloa JJ. Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention and treatment. J Oral Maxillofac Surg. 2007 ; 65: 2397-2410 (Pubitemid 350100982)
12. Midtby M, Magnus JH, Joakimsen RM. The Tromsø Study: a population-based study on the variation in bone formation markers with age, gender, anthropometry and season in both men and women. Osteoporos Int. 2001 ; 12: 835-843 (Pubitemid 33086270)
13. Ortman LF, McHenry K, Hausmann E. Relationship between alveolar bone measured by 125I absorptiometry with analysis of standardized radiographs: 2. Bjorn technique. J Periodontol. 1982 ; 53: 311-314 (Pubitemid 12014291)
14. Payne JB, Golub LM. Using tetracyclines to treat osteoporotic/osteopenic bone loss: from the basic science laboratory to the clinic. Pharmacol Res. 2011 ; 63: 121-129
15. Payne JB, Reinhardt RA, Nummikoski PV, Patil KD. Longitudinal alveolar bone loss in postmenopausal osteoporotic/osteopenic women. Osteoporos Int. 1999 ; 10: 34-40 (Pubitemid 29428012)
16. Payne JB, Stoner JA, Nummikoski PV, Reinhardt RA, Goren AD, Wolff MS, et al. Subantimicrobial dose doxycycline effects on alveolar bone loss in post-menopausal women. J Clin Periodontol. 2007 ; 34: 776-787
17. Population Division, US Census Bureau (2008). Table 2. Projections of the Population by Selected Age Groups and Sex for the United States: 2010 to 2050 (NP2008-T2), Release Date: August 14, 2008. URL available at: http://www.census.gov/population/www/projections/files/nation/summary/np2008-t2. xls. (accessed January 21, 2011).
18. Seibel MJ. Biochemical markers of bone turnover. Part I: biochemistry and variability. Clin Biochem Rev. 2005 ; 26: 97-122
19. Seibel MJ. Biochemical markers of bone turnover. Part II: clinical applications in the management of osteoporosis. Clin Biochem Rev. 2006 ; 27: 123-138
20. US DHHS (2004). Bone health and osteoporosis: A Report of the Surgeon General. Rockville, MD: US Department of Health and Human Services, Office of the Surgeon General. URL available at:http://www.surgeongeneral.gov/library/ bonehealth/content.html (accessed 01/21/ 2011).